img

Global Meloxicam Drug Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Meloxicam Drug Market Research Report 2024

Meloxicam (Mobic) is used to treat pain or inflammation caused by osteoarthritis or rheumatoid arthritis. 
According to Mr Accuracy reports new survey, global Meloxicam Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Meloxicam Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Meloxicam Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Boehringer-Ingelheim
TerSera Therapeutics
Iroko Pharmaceuticals
Apotex
Yung Shin Pharmaceutical
Breckenridge Pharmaceutical
Zydus Pharmaceuticals
Unichem Pharmaceuticals
Strides Pharma
Cipla
Dr. Reddy's Laboratories
Glenmark Pharmaceuticals
Teva
PuraCap Pharmaceutical
TARO
Lupin Pharmaceuticals
Aurobindo Pharma
Segment by Type
Tablet
Capsule

Segment by Application


Osteoarthritis in Adults (OA)
Rheumatoid Arthritis in Adults (RA)
Pediatric Patients

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Meloxicam Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Meloxicam Drug Market Overview
1.1 Product Overview and Scope of Meloxicam Drug
1.2 Meloxicam Drug Segment by Type
1.2.1 Global Meloxicam Drug Market Value Comparison by Type (2024-2034)
1.2.2 Tablet
1.2.3 Capsule
1.3 Meloxicam Drug Segment by Application
1.3.1 Global Meloxicam Drug Market Value by Application: (2024-2034)
1.3.2 Osteoarthritis in Adults (OA)
1.3.3 Rheumatoid Arthritis in Adults (RA)
1.3.4 Pediatric Patients
1.4 Global Meloxicam Drug Market Size Estimates and Forecasts
1.4.1 Global Meloxicam Drug Revenue 2018-2029
1.4.2 Global Meloxicam Drug Sales 2018-2029
1.4.3 Global Meloxicam Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Meloxicam Drug Market Competition by Manufacturers
2.1 Global Meloxicam Drug Sales Market Share by Manufacturers (2018-2024)
2.2 Global Meloxicam Drug Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Meloxicam Drug Average Price by Manufacturers (2018-2024)
2.4 Global Meloxicam Drug Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Meloxicam Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Meloxicam Drug, Product Type & Application
2.7 Meloxicam Drug Market Competitive Situation and Trends
2.7.1 Meloxicam Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Meloxicam Drug Players Market Share by Revenue
2.7.3 Global Meloxicam Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Meloxicam Drug Retrospective Market Scenario by Region
3.1 Global Meloxicam Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Meloxicam Drug Global Meloxicam Drug Sales by Region: 2018-2029
3.2.1 Global Meloxicam Drug Sales by Region: 2018-2024
3.2.2 Global Meloxicam Drug Sales by Region: 2024-2029
3.3 Global Meloxicam Drug Global Meloxicam Drug Revenue by Region: 2018-2029
3.3.1 Global Meloxicam Drug Revenue by Region: 2018-2024
3.3.2 Global Meloxicam Drug Revenue by Region: 2024-2029
3.4 North America Meloxicam Drug Market Facts & Figures by Country
3.4.1 North America Meloxicam Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Meloxicam Drug Sales by Country (2018-2029)
3.4.3 North America Meloxicam Drug Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Meloxicam Drug Market Facts & Figures by Country
3.5.1 Europe Meloxicam Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Meloxicam Drug Sales by Country (2018-2029)
3.5.3 Europe Meloxicam Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meloxicam Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Meloxicam Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Meloxicam Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Meloxicam Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Meloxicam Drug Market Facts & Figures by Country
3.7.1 Latin America Meloxicam Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Meloxicam Drug Sales by Country (2018-2029)
3.7.3 Latin America Meloxicam Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Meloxicam Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Meloxicam Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Meloxicam Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Meloxicam Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Meloxicam Drug Sales by Type (2018-2029)
4.1.1 Global Meloxicam Drug Sales by Type (2018-2024)
4.1.2 Global Meloxicam Drug Sales by Type (2024-2029)
4.1.3 Global Meloxicam Drug Sales Market Share by Type (2018-2029)
4.2 Global Meloxicam Drug Revenue by Type (2018-2029)
4.2.1 Global Meloxicam Drug Revenue by Type (2018-2024)
4.2.2 Global Meloxicam Drug Revenue by Type (2024-2029)
4.2.3 Global Meloxicam Drug Revenue Market Share by Type (2018-2029)
4.3 Global Meloxicam Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Meloxicam Drug Sales by Application (2018-2029)
5.1.1 Global Meloxicam Drug Sales by Application (2018-2024)
5.1.2 Global Meloxicam Drug Sales by Application (2024-2029)
5.1.3 Global Meloxicam Drug Sales Market Share by Application (2018-2029)
5.2 Global Meloxicam Drug Revenue by Application (2018-2029)
5.2.1 Global Meloxicam Drug Revenue by Application (2018-2024)
5.2.2 Global Meloxicam Drug Revenue by Application (2024-2029)
5.2.3 Global Meloxicam Drug Revenue Market Share by Application (2018-2029)
5.3 Global Meloxicam Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Boehringer-Ingelheim
6.1.1 Boehringer-Ingelheim Corporation Information
6.1.2 Boehringer-Ingelheim Description and Business Overview
6.1.3 Boehringer-Ingelheim Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Boehringer-Ingelheim Meloxicam Drug Product Portfolio
6.1.5 Boehringer-Ingelheim Recent Developments/Updates
6.2 TerSera Therapeutics
6.2.1 TerSera Therapeutics Corporation Information
6.2.2 TerSera Therapeutics Description and Business Overview
6.2.3 TerSera Therapeutics Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
6.2.4 TerSera Therapeutics Meloxicam Drug Product Portfolio
6.2.5 TerSera Therapeutics Recent Developments/Updates
6.3 Iroko Pharmaceuticals
6.3.1 Iroko Pharmaceuticals Corporation Information
6.3.2 Iroko Pharmaceuticals Description and Business Overview
6.3.3 Iroko Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Iroko Pharmaceuticals Meloxicam Drug Product Portfolio
6.3.5 Iroko Pharmaceuticals Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Corporation Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Apotex Meloxicam Drug Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Yung Shin Pharmaceutical
6.5.1 Yung Shin Pharmaceutical Corporation Information
6.5.2 Yung Shin Pharmaceutical Description and Business Overview
6.5.3 Yung Shin Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Yung Shin Pharmaceutical Meloxicam Drug Product Portfolio
6.5.5 Yung Shin Pharmaceutical Recent Developments/Updates
6.6 Breckenridge Pharmaceutical
6.6.1 Breckenridge Pharmaceutical Corporation Information
6.6.2 Breckenridge Pharmaceutical Description and Business Overview
6.6.3 Breckenridge Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Breckenridge Pharmaceutical Meloxicam Drug Product Portfolio
6.6.5 Breckenridge Pharmaceutical Recent Developments/Updates
6.7 Zydus Pharmaceuticals
6.6.1 Zydus Pharmaceuticals Corporation Information
6.6.2 Zydus Pharmaceuticals Description and Business Overview
6.6.3 Zydus Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Zydus Pharmaceuticals Meloxicam Drug Product Portfolio
6.7.5 Zydus Pharmaceuticals Recent Developments/Updates
6.8 Unichem Pharmaceuticals
6.8.1 Unichem Pharmaceuticals Corporation Information
6.8.2 Unichem Pharmaceuticals Description and Business Overview
6.8.3 Unichem Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Unichem Pharmaceuticals Meloxicam Drug Product Portfolio
6.8.5 Unichem Pharmaceuticals Recent Developments/Updates
6.9 Strides Pharma
6.9.1 Strides Pharma Corporation Information
6.9.2 Strides Pharma Description and Business Overview
6.9.3 Strides Pharma Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Strides Pharma Meloxicam Drug Product Portfolio
6.9.5 Strides Pharma Recent Developments/Updates
6.10 Cipla
6.10.1 Cipla Corporation Information
6.10.2 Cipla Description and Business Overview
6.10.3 Cipla Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Cipla Meloxicam Drug Product Portfolio
6.10.5 Cipla Recent Developments/Updates
6.11 Dr. Reddy's Laboratories
6.11.1 Dr. Reddy's Laboratories Corporation Information
6.11.2 Dr. Reddy's Laboratories Meloxicam Drug Description and Business Overview
6.11.3 Dr. Reddy's Laboratories Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Dr. Reddy's Laboratories Meloxicam Drug Product Portfolio
6.11.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.12 Glenmark Pharmaceuticals
6.12.1 Glenmark Pharmaceuticals Corporation Information
6.12.2 Glenmark Pharmaceuticals Meloxicam Drug Description and Business Overview
6.12.3 Glenmark Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Glenmark Pharmaceuticals Meloxicam Drug Product Portfolio
6.12.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.13 Teva
6.13.1 Teva Corporation Information
6.13.2 Teva Meloxicam Drug Description and Business Overview
6.13.3 Teva Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Teva Meloxicam Drug Product Portfolio
6.13.5 Teva Recent Developments/Updates
6.14 PuraCap Pharmaceutical
6.14.1 PuraCap Pharmaceutical Corporation Information
6.14.2 PuraCap Pharmaceutical Meloxicam Drug Description and Business Overview
6.14.3 PuraCap Pharmaceutical Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
6.14.4 PuraCap Pharmaceutical Meloxicam Drug Product Portfolio
6.14.5 PuraCap Pharmaceutical Recent Developments/Updates
6.15 TARO
6.15.1 TARO Corporation Information
6.15.2 TARO Meloxicam Drug Description and Business Overview
6.15.3 TARO Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
6.15.4 TARO Meloxicam Drug Product Portfolio
6.15.5 TARO Recent Developments/Updates
6.16 Lupin Pharmaceuticals
6.16.1 Lupin Pharmaceuticals Corporation Information
6.16.2 Lupin Pharmaceuticals Meloxicam Drug Description and Business Overview
6.16.3 Lupin Pharmaceuticals Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Lupin Pharmaceuticals Meloxicam Drug Product Portfolio
6.16.5 Lupin Pharmaceuticals Recent Developments/Updates
6.17 Aurobindo Pharma
6.17.1 Aurobindo Pharma Corporation Information
6.17.2 Aurobindo Pharma Meloxicam Drug Description and Business Overview
6.17.3 Aurobindo Pharma Meloxicam Drug Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Aurobindo Pharma Meloxicam Drug Product Portfolio
6.17.5 Aurobindo Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meloxicam Drug Industry Chain Analysis
7.2 Meloxicam Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meloxicam Drug Production Mode & Process
7.4 Meloxicam Drug Sales and Marketing
7.4.1 Meloxicam Drug Sales Channels
7.4.2 Meloxicam Drug Distributors
7.5 Meloxicam Drug Customers
8 Meloxicam Drug Market Dynamics
8.1 Meloxicam Drug Industry Trends
8.2 Meloxicam Drug Market Drivers
8.3 Meloxicam Drug Market Challenges
8.4 Meloxicam Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Meloxicam Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Meloxicam Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Meloxicam Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Meloxicam Drug Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Meloxicam Drug Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Meloxicam Drug Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Meloxicam Drug Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Meloxicam Drug Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Meloxicam Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Meloxicam Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Meloxicam Drug, Product Type & Application
Table 12. Global Key Manufacturers of Meloxicam Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Meloxicam Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meloxicam Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Meloxicam Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Meloxicam Drug Sales by Region (2018-2024) & (K Units)
Table 18. Global Meloxicam Drug Sales Market Share by Region (2018-2024)
Table 19. Global Meloxicam Drug Sales by Region (2024-2029) & (K Units)
Table 20. Global Meloxicam Drug Sales Market Share by Region (2024-2029)
Table 21. Global Meloxicam Drug Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Meloxicam Drug Revenue Market Share by Region (2018-2024)
Table 23. Global Meloxicam Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Meloxicam Drug Revenue Market Share by Region (2024-2029)
Table 25. North America Meloxicam Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Meloxicam Drug Sales by Country (2018-2024) & (K Units)
Table 27. North America Meloxicam Drug Sales by Country (2024-2029) & (K Units)
Table 28. North America Meloxicam Drug Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Meloxicam Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Meloxicam Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Meloxicam Drug Sales by Country (2018-2024) & (K Units)
Table 32. Europe Meloxicam Drug Sales by Country (2024-2029) & (K Units)
Table 33. Europe Meloxicam Drug Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Meloxicam Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Meloxicam Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Meloxicam Drug Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Meloxicam Drug Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Meloxicam Drug Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Meloxicam Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Meloxicam Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Meloxicam Drug Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Meloxicam Drug Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Meloxicam Drug Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Meloxicam Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Meloxicam Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Meloxicam Drug Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Meloxicam Drug Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Meloxicam Drug Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Meloxicam Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Meloxicam Drug Sales (K Units) by Type (2018-2024)
Table 51. Global Meloxicam Drug Sales (K Units) by Type (2024-2029)
Table 52. Global Meloxicam Drug Sales Market Share by Type (2018-2024)
Table 53. Global Meloxicam Drug Sales Market Share by Type (2024-2029)
Table 54. Global Meloxicam Drug Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Meloxicam Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Meloxicam Drug Revenue Market Share by Type (2018-2024)
Table 57. Global Meloxicam Drug Revenue Market Share by Type (2024-2029)
Table 58. Global Meloxicam Drug Price (USD/Unit) by Type (2018-2024)
Table 59. Global Meloxicam Drug Price (USD/Unit) by Type (2024-2029)
Table 60. Global Meloxicam Drug Sales (K Units) by Application (2018-2024)
Table 61. Global Meloxicam Drug Sales (K Units) by Application (2024-2029)
Table 62. Global Meloxicam Drug Sales Market Share by Application (2018-2024)
Table 63. Global Meloxicam Drug Sales Market Share by Application (2024-2029)
Table 64. Global Meloxicam Drug Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Meloxicam Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Meloxicam Drug Revenue Market Share by Application (2018-2024)
Table 67. Global Meloxicam Drug Revenue Market Share by Application (2024-2029)
Table 68. Global Meloxicam Drug Price (USD/Unit) by Application (2018-2024)
Table 69. Global Meloxicam Drug Price (USD/Unit) by Application (2024-2029)
Table 70. Boehringer-Ingelheim Corporation Information
Table 71. Boehringer-Ingelheim Description and Business Overview
Table 72. Boehringer-Ingelheim Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Boehringer-Ingelheim Meloxicam Drug Product
Table 74. Boehringer-Ingelheim Recent Developments/Updates
Table 75. TerSera Therapeutics Corporation Information
Table 76. TerSera Therapeutics Description and Business Overview
Table 77. TerSera Therapeutics Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. TerSera Therapeutics Meloxicam Drug Product
Table 79. TerSera Therapeutics Recent Developments/Updates
Table 80. Iroko Pharmaceuticals Corporation Information
Table 81. Iroko Pharmaceuticals Description and Business Overview
Table 82. Iroko Pharmaceuticals Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. Iroko Pharmaceuticals Meloxicam Drug Product
Table 84. Iroko Pharmaceuticals Recent Developments/Updates
Table 85. Apotex Corporation Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Apotex Meloxicam Drug Product
Table 89. Apotex Recent Developments/Updates
Table 90. Yung Shin Pharmaceutical Corporation Information
Table 91. Yung Shin Pharmaceutical Description and Business Overview
Table 92. Yung Shin Pharmaceutical Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. Yung Shin Pharmaceutical Meloxicam Drug Product
Table 94. Yung Shin Pharmaceutical Recent Developments/Updates
Table 95. Breckenridge Pharmaceutical Corporation Information
Table 96. Breckenridge Pharmaceutical Description and Business Overview
Table 97. Breckenridge Pharmaceutical Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. Breckenridge Pharmaceutical Meloxicam Drug Product
Table 99. Breckenridge Pharmaceutical Recent Developments/Updates
Table 100. Zydus Pharmaceuticals Corporation Information
Table 101. Zydus Pharmaceuticals Description and Business Overview
Table 102. Zydus Pharmaceuticals Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. Zydus Pharmaceuticals Meloxicam Drug Product
Table 104. Zydus Pharmaceuticals Recent Developments/Updates
Table 105. Unichem Pharmaceuticals Corporation Information
Table 106. Unichem Pharmaceuticals Description and Business Overview
Table 107. Unichem Pharmaceuticals Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 108. Unichem Pharmaceuticals Meloxicam Drug Product
Table 109. Unichem Pharmaceuticals Recent Developments/Updates
Table 110. Strides Pharma Corporation Information
Table 111. Strides Pharma Description and Business Overview
Table 112. Strides Pharma Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Strides Pharma Meloxicam Drug Product
Table 114. Strides Pharma Recent Developments/Updates
Table 115. Cipla Corporation Information
Table 116. Cipla Description and Business Overview
Table 117. Cipla Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. Cipla Meloxicam Drug Product
Table 119. Cipla Recent Developments/Updates
Table 120. Dr. Reddy's Laboratories Corporation Information
Table 121. Dr. Reddy's Laboratories Description and Business Overview
Table 122. Dr. Reddy's Laboratories Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. Dr. Reddy's Laboratories Meloxicam Drug Product
Table 124. Dr. Reddy's Laboratories Recent Developments/Updates
Table 125. Glenmark Pharmaceuticals Corporation Information
Table 126. Glenmark Pharmaceuticals Description and Business Overview
Table 127. Glenmark Pharmaceuticals Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. Glenmark Pharmaceuticals Meloxicam Drug Product
Table 129. Glenmark Pharmaceuticals Recent Developments/Updates
Table 130. Teva Corporation Information
Table 131. Teva Description and Business Overview
Table 132. Teva Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. Teva Meloxicam Drug Product
Table 134. Teva Recent Developments/Updates
Table 135. PuraCap Pharmaceutical Corporation Information
Table 136. PuraCap Pharmaceutical Description and Business Overview
Table 137. PuraCap Pharmaceutical Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 138. PuraCap Pharmaceutical Meloxicam Drug Product
Table 139. PuraCap Pharmaceutical Recent Developments/Updates
Table 140. TARO Corporation Information
Table 141. TARO Description and Business Overview
Table 142. TARO Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 143. TARO Meloxicam Drug Product
Table 144. TARO Recent Developments/Updates
Table 145. Lupin Pharmaceuticals Corporation Information
Table 146. Lupin Pharmaceuticals Description and Business Overview
Table 147. Lupin Pharmaceuticals Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 148. Lupin Pharmaceuticals Meloxicam Drug Product
Table 149. Lupin Pharmaceuticals Recent Developments/Updates
Table 150. Aurobindo Pharma Corporation Information
Table 151. Aurobindo Pharma Description and Business Overview
Table 152. Aurobindo Pharma Meloxicam Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 153. Aurobindo Pharma Meloxicam Drug Product
Table 154. Aurobindo Pharma Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Meloxicam Drug Distributors List
Table 158. Meloxicam Drug Customers List
Table 159. Meloxicam Drug Market Trends
Table 160. Meloxicam Drug Market Drivers
Table 161. Meloxicam Drug Market Challenges
Table 162. Meloxicam Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Meloxicam Drug
Figure 2. Global Meloxicam Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Meloxicam Drug Market Share by Type in 2022 & 2029
Figure 4. Tablet Product Picture
Figure 5. Capsule Product Picture
Figure 6. Global Meloxicam Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Meloxicam Drug Market Share by Application in 2022 & 2029
Figure 8. Osteoarthritis in Adults (OA)
Figure 9. Rheumatoid Arthritis in Adults (RA)
Figure 10. Pediatric Patients
Figure 11. Global Meloxicam Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Meloxicam Drug Market Size (2018-2029) & (US$ Million)
Figure 13. Global Meloxicam Drug Sales (2018-2029) & (K Units)
Figure 14. Global Meloxicam Drug Average Price (USD/Unit) & (2018-2029)
Figure 15. Meloxicam Drug Report Years Considered
Figure 16. Meloxicam Drug Sales Share by Manufacturers in 2022
Figure 17. Global Meloxicam Drug Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Meloxicam Drug Players: Market Share by Revenue in 2022
Figure 19. Meloxicam Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Meloxicam Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Meloxicam Drug Sales Market Share by Country (2018-2029)
Figure 22. North America Meloxicam Drug Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Meloxicam Drug Sales Market Share by Country (2018-2029)
Figure 26. Europe Meloxicam Drug Revenue Market Share by Country (2018-2029)
Figure 27. Germany Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Meloxicam Drug Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Meloxicam Drug Revenue Market Share by Region (2018-2029)
Figure 34. China Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Meloxicam Drug Sales Market Share by Country (2018-2029)
Figure 45. Latin America Meloxicam Drug Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Meloxicam Drug Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Meloxicam Drug Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Meloxicam Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Meloxicam Drug by Type (2018-2029)
Figure 55. Global Revenue Market Share of Meloxicam Drug by Type (2018-2029)
Figure 56. Global Meloxicam Drug Price (USD/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Meloxicam Drug by Application (2018-2029)
Figure 58. Global Revenue Market Share of Meloxicam Drug by Application (2018-2029)
Figure 59. Global Meloxicam Drug Price (USD/Unit) by Application (2018-2029)
Figure 60. Meloxicam Drug Value Chain
Figure 61. Meloxicam Drug Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries